Search research articles
Contact Us
Filters
Showing results (1-10 of 130) with videos related to
Page
of 13
Sort By:
Alcoholism, Clinical and Experimental Research
|
February 1, 1987
Essential fatty acids, prostaglandins, and nonsteroidal antiinflammatory agents: physiological and behavioral interactions
D Segarnick, J Rotrosen
The Journal of Pharmacy and Pharmacology
|
December 1, 1984
Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligands
D E Wazer, J Rotrosen
Biological Psychiatry
|
November 1, 1986
Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics
P Fiedler, A Wolkin, J Rotrosen
Psychopharmacology
|
November 20, 2001
Commentary on: "Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia." Psychopharmacology (1980) 72:17-19
B Angrist, J Rotrosen, S Gershon
British Journal of Pharmacology
|
May 1, 1975
Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brain
E Friedman, S Gershon, J Rotrosen
Psychopharmacology Bulletin
|
January 1, 1978
Neuroendocrine studies with dopamine agonists in schizophrenia
J Rotrosen, B Angrist, J Paquin
Life Sciences
|
August 15, 1975
Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats
J Rotrosen, E Friedman, S Gershon
Psychopharmacology
|
January 1, 1980
Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia
B Angrist, J Rotrosen, S Gershon
Psychopharmacology
|
January 1, 1980
Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects
B Angrist, J Rotrosen, S Gershon
Psychopharmacology Bulletin
|
January 1, 1980
Assessment of dopaminergic function in schizophrenia [proceedings]
B Angrist, J Rotrosen, S Gershon
Page
of 13
Search research articles
Search
Showing results (1-10 of 130) with videos related to
Sort By:
Page
of 13
Alcoholism, Clinical and Experimental Research
|
February 1, 1987
Essential fatty acids, prostaglandins, and nonsteroidal antiinflammatory agents: physiological and behavioral interactions
D Segarnick, J Rotrosen
The Journal of Pharmacy and Pharmacology
|
December 1, 1984
Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligands
D E Wazer, J Rotrosen
Biological Psychiatry
|
November 1, 1986
Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics
P Fiedler, A Wolkin, J Rotrosen
Psychopharmacology
|
November 20, 2001
Commentary on: "Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia." Psychopharmacology (1980) 72:17-19
B Angrist, J Rotrosen, S Gershon
British Journal of Pharmacology
|
May 1, 1975
Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brain
E Friedman, S Gershon, J Rotrosen
Psychopharmacology Bulletin
|
January 1, 1978
Neuroendocrine studies with dopamine agonists in schizophrenia
J Rotrosen, B Angrist, J Paquin
Life Sciences
|
August 15, 1975
Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats
J Rotrosen, E Friedman, S Gershon
Psychopharmacology
|
January 1, 1980
Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia
B Angrist, J Rotrosen, S Gershon
Psychopharmacology
|
January 1, 1980
Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects
B Angrist, J Rotrosen, S Gershon
Psychopharmacology Bulletin
|
January 1, 1980
Assessment of dopaminergic function in schizophrenia [proceedings]
B Angrist, J Rotrosen, S Gershon
Page
of 13